TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

LUMIFY PRESERVATIVE FREE

BRIMONIDINE TARTRATE
Approved 2024-04-19
1
Indication
--
Phase 3 Trials
1
Years on Market

Details

Status
Over-the-counter
First Approved
2024-04-19
Routes
OPHTHALMIC
Dosage Forms
SOLUTION/DROPS

Companies

Active Ingredient: BRIMONIDINE TARTRATE

LUMIFY PRESERVATIVE FREE Approval History

Loading approval history...

What LUMIFY PRESERVATIVE FREE Treats

1 FDA approvals

Originally approved for its first indication in 2024 .

  • Other (1)
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

LUMIFY PRESERVATIVE FREE FDA Label Details

Pro

LUMIFY PRESERVATIVE FREE Patents & Exclusivity

Latest Patent: Jul 2030

Patents (3 active)

US9259425 Expires Jul 14, 2030
US8293742 Expires Jul 14, 2030
US11596600 Expires Jul 27, 2029
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.